Kuke Music Holding (NYSE:KUKE) reported quarterly losses of $(0.07) per share. The company reported $13.00 million in sales this quarter.
HC Wainwright & Co. Maintains Buy on First Wave BioPharma, Lowers Price Target to $4
HC Wainwright & Co. analyst Yi Chen maintains First Wave BioPharma (NASDAQ:FWBI) with a Buy and lowers the price target from $8 to $4.